Trademark Details For CITRANATAL MEDLEY (Serial Number 87396796)

  •  Home
  •  Print
CITRANATAL MEDLEY
1
7
2
0
Serial Number  United States - USPTO 87396796
Registration Number 5587153
Mark
CITRANATAL MEDLEY
Filing Date Apr-03-2017
Status
Registered  
REGISTERED (700)
REGISTERED
Attorney Name
TTAB
0




005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Jul-24-2018

First Use in Commerce: Jul-24-2018





Correspondences

NamePamela B. Huff Schwegman Lundberg Woessner P.A.
AddressPO Box 2938 Minneapolis, MN 55402 United States

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Apr-06-2017NEW APPLICATION ENTERED   NWAPI
Apr-10-2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Jun-02-2017ASSIGNED TO EXAMINER   DOCKD
Jun-07-2017APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Jun-20-2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
Jun-20-2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
Jun-28-2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Jul-18-2017PUBLISHED FOR OPPOSITION   PUBOA
Jul-18-2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Sep-12-2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Mar-05-2018SOU TEAS EXTENSION RECEIVED   EEXTI
Mar-05-2018SOU EXTENSION 1 FILED   EXT1S
Mar-05-2018SOU EXTENSION 1 GRANTED   EX1GS
Mar-07-2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Jul-26-2018TEAS STATEMENT OF USE RECEIVED   EISUI
Aug-22-2018CASE ASSIGNED TO INTENT TO USE PARALEGAL   AITUA
Jul-26-2018USE AMENDMENT FILED   IUAFS
Aug-22-2018STATEMENT OF USE PROCESSING COMPLETE   SUPCI
Sep-11-2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED   CNPRP
Sep-12-2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED   SUNAE
Oct-16-2018REGISTERED-PRINCIPAL REGISTER   R.PRA
Mar-03-2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY   ASCKI
Oct-16-2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Oct-04-2024TEAS SECTION 8 & 15 RECEIVED   E815I